Companies and Markets - Page 2
Stay up to date with the latest Companies and Markets updates from the global pharmaceutical industryAmylin Pharmaceuticals to look for buyer
Amylin Pharmaceuticals has hired Credit Suisse and Goldman Sachs in an attempt to find a potential buyer, according to...
AstraZeneca to acquire Ardea Biosciences for $1.26bn
AstraZeneca has agreed to acquire US-based biotechnology company Ardea Biosciences for...
GlaxoSmithKline fails in bid to buy Human Genome Sciences
UK-based pharmaceutical major GlaxoSmithKline’s (GSK) $2.6bn bid to acquire US biotechnology firm Human Genome Sciences (HGS) has...
UK scientists show support for Tracking Parkinson’s study
Healthcare facilities and clinical researchers around the UK have announced that they will play a key role in the Tracking Parkinson’s study, the world’s biggest study into the cause of the...
Merck enters into agreement with Endocyte over cancer drug vintafolide
Merck has entered into an agreement with Endocyte to develop and commercialise the latter’s investigational cancer drug vintafolide which could be worth up to...
Piramal acquires Bayer R&D portfolio
India-based pharmaceutical company Piramal has agreed to acquire a research and development portfolio from Germany-based Bayer AG, including a potential treatment for...
Takeda to acquire URL Pharma for $800m
Japan-based drug manufacturer Takeda Pharmaceutical is to acquire the US pharmaceutical firm URL Pharma for an upfront payment of...
Amgen acquires KAI Pharma for $315m
Amgen has acquired privately-owned KAI Pharmaceuticals for $315m and gained access to its secondary hyperparathyroidism drug...
Illumina urges shareholders to reject Roche offer following ISS report
Illumina has sent a fourth letter to stockholders urging them to reject Roche’s latest offer of $51 per share, again claiming the offer to be “grossly...
AstraZeneca, Amgen to develop antibodies for inflammatory disorders
AstraZeneca has agreed to jointly develop and commercialise five monoclonal antibodies from Amgen's clinical inflammation...
Ilumina rejects Roche’s takeover offer
US genetic sequencing company Ilumina has rejected Roche’s increased takeover offer, stating that it “dramatically undervalues” the...
Optimer, Astellas to develop drugs for CDI superbug
US-based Optimer Pharmaceuticals has joined forces with Tokyo’s Astellas Pharma to develop DIFICID (fidaxomicin) tablets in Japan for the treatment of superbug Clostridium difficile...
Roche increase Illumina bid by 15%
Switzerland-based pharmaceutical company Roche has increased its hostile takeover bid for Illumina by 15%, raising its price per share offer to...
Inovio Pharmaceuticals’ multi-strain flu vaccine gets US patent
Inovio Pharmaceuticals’ SynCon vaccine which targets multi strains of influenza has received patent protection from the US Patent and Trademark...
Teva launches Seroquel generic
Israel-based generic drug manufacturer Teva Pharmaceuticals has launched a generic version of AstraZeneca’s antipsychotic drug Seroquel just hours after another failed bid to protect its...
Bayer HealthCare, Tsinghua University expand drug discovery agreement
Bayer HealthCare Company and Tsinghua University in Beijing, China, have agreed to expand their joint research partnership for drug...
Roche extends Illumina bid for a second time
Switzerland-based pharmaceutical firm Roche has extended its cash tender offer to acquire all outstanding shares in Illumina for a second...
Roche slashes India cancer drug prices
Switzerland-based pharmaceutical company Roche is slashing the price of two cancer drugs in India to fend off increasing competition from generic...
Watson to acquire Switzerland’s Actavis
US-based generic pharmaceutical firm Watson Pharmaceuticals is in talks to acquire Switzerland-based Actavis, according to...
GlaxoSmithKline to invest £500m in UK facilities
UK-based pharmaceutical major GlaxoSmithKline has revealed plans to invest £500m in manufacturing facilities within the UK, including a new factory to be constructed in Ulverston,...
Twitter